Cat.No.: | BSM-0316 |
Product Name: | TZ9 |
CAS No.: | 1002789-86-7 |
Figure: | |
Product Overview: | A Rad6B inhibitor |
Description: | TZ9 is a cell-permeable triazine compound that inhibits the human E2 ubiquitin-conjugating enzyme Rad6B. TZ9 selectively docks to the Rad6B catalytic site, inhibits Rad6B-induced histone H2A ubiquitination, downregulates intracellular β-catenin, induces G2/M arrest and apoptosis, and inhibits proliferation and migration of metastatic human breast cancer cells (IC50 = 6 µM). |
Appearance: | A crystalline solid |
Molecular Weight: | 366.3 |
Purity: | ≥98% |
Storage: | -20°C |
Targets: | Rad6B |
Molecular Formula: | C17H14N6O4 |
Chemical Name: | 4-amino-6-(phenylamino)-2-(4-nitrobenzoate)-1,3,5-triazine-2-methanol |
Warning: | For Research Use Only! Not For Use in Humans. |
Product Types | ||
◆ Antibodies | ||
EAb-0044 | RARA Polyclonal Antibody | Inquiry |
EAb-0356 | RAD54L2 Polyclonal Antibody | Inquiry |
◆ Bioactive Small Molecules | ||
BSM-0316 | TZ9 | Inquiry |
◆ Cell Lines | ||
CL-0390 | Human RAD52 Knockout Cell Line 2bp insertion | Inquiry |
◆ Proteins & Enzymes | ||
PE-1231 | Recombinant Human RAC3, His-tagged | Inquiry |
Related Gene / Proteins | |||
RAC3 | Rad21 | RAD52 | RAD54L2 |
Rad6 | Rad6B | RAG1 | RAG2 |
RALY | RALYL | RANBP2 | RAP1 |
RAR-β | RAR-γ | RARA |
USA
Enter your email here to subscribe.
Follow us on
Easy access to products and services you need from our library via powerful searching tools